Phytocannabinoids and Male Fertility: Implications of Cannabis sativa and the Endocannabinoid System in Reproductive Regulation
Plants · 03.02.2026 · 15 (3) · 473
DOI: 10.3390/plants15030473 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Plants, online erschienen am 03.02.2026. Verfasst von Ochuko L Erukainure und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, School of Life Sciences, University of KwaZulu-Natal, Durban 4000, South Africa. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation, National Research Foundation (NRF), Pretoria, South Africa.
Abstract (Originalsprache)
Cannabis sativa, a species within the Cannabaceae family, produces a diverse range of phytochemicals, notably cannabinoids and terpenoids, with significant physiological and pharmacological relevance. Among its phytochemicals, Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are the most studied for their psychoactive and medicinal properties. However, emerging evidence indicates that chronic or excessive exposure to these phytocannabinoids may adversely affect male fertility. This review synthesizes current knowledge on the influence of C. sativa and its constituents on the male reproductive system, with emphasis on spermatogenesis, sperm function, hormonal regulation, and the role of the endocannabinoid system (ECS). Experimental and clinical studies demonstrate that cannabinoids interact with CB1 and CB2 receptors expressed in the testes, epididymis, and spermatozoa, thereby modulating testosterone synthesis, sperm motility, morphology, and capacitation. THC, in particular, disrupts the hypothalamic–pituitary–gonadal (HPG) axis, leading to reduced luteinizing hormone and testosterone levels, impaired mitochondrial activity, and abnormal sperm morphology. Although CBD exhibits anti-inflammatory and antioxidant properties, its long-term impact on reproductive function remains uncertain. The review further highlights the complex interplay between exogenous cannabinoids and the endogenous ECS in maintaining reproductive homeostasis. Understanding these molecular mechanisms is critical for balancing the therapeutic potential of Cannabis-derived products with their reproductive risks. This knowledge could inform safe medicinal applications and contribute to the development of targeted cannabinoid-based therapies for male infertility.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology, School of Life Sciences, University of KwaZulu-Natal, Durban 4000, South Africa.
- Department of Biochemistry, School of Life Sciences, University of KwaZulu-Natal, Durban 4000, South Africa.
- Department of Chemistry, Faculty of Natural and Agriculture Science, University of Free State, Bloemfontein 9300, South Africa.
- Centre for Quality of Health and Living (CQHL), Faculty of Health and Environmental Sciences, Central University of Technology, Bloemfontein 9301, South Africa.
ORCID-Profile: Ochuko L Erukainure, Jennifer Nambooze
Förderung
- National Research Foundation
- National Research Foundation (NRF), Pretoria, South Africa
Zitieren
APA
Erukainure, O. L., Nambooze, J., & Chukwuma, C. I. (2026). Phytocannabinoids and Male Fertility: Implications of Cannabis sativa and the Endocannabinoid System in Reproductive Regulation. Plants, 15(3), 473. https://doi.org/10.3390/plants15030473
Vancouver
Erukainure OL, Nambooze J, Chukwuma CI. Phytocannabinoids and Male Fertility: Implications of Cannabis sativa and the Endocannabinoid System in Reproductive Regulation. Plants. 2026;15(3):473. doi:10.3390/plants15030473
BibTeX
@article{Erukainure2026,
author = {Erukainure, Ochuko L and Nambooze, Jennifer and Chukwuma, Chika I},
title = {Phytocannabinoids and Male Fertility: Implications of Cannabis sativa and the Endocannabinoid System in Reproductive Regulation},
journal = {Plants},
year = {2026},
volume = {15},
number = {3},
pages = {473},
doi = {10.3390/plants15030473}
}
EUVIMED